Anti-HIV activity of new higher order G-quadruplex aptamers obtained from tetra-end-linked oligonucleotides
Literature Information
F. Nici, G. Oliviero, A. P. Falanga, S. D'Errico, M. Marzano, D. Musumeci, D. Montesarchio, S. Noppen, C. Pannecouque, G. Piccialli, N. Borbone
By combining the ability of short G-rich oligodeoxyribonucleotides (ODNs) containing the sequence 5′CGGA3′ to form higher order G-quadruplex (G4) complexes with the tetra-end-linked (TEL) concept to produce aptamers targeting the HIV envelope glycoprotein 120 (gp120), three new TEL-ODNs (1–3) having the sequence 5′CGGAGG3′ were synthesized with the aim of studying the effect of G4 dimerization on their anti-HIV activity. Furthermore, in order to investigate the effect of the groups at the 5′ position, the 5′ ends of 1–3 were left uncapped (1) or capped with either the lipophilic dimethoxytrityl (DMT) (2) or the hydrophilic glucosyl-4-phosphate (3) moieties. The here reported results demonstrate that only the DMT-substituted TEL-ODN 2 is effective in protecting human MT-4 cell cultures from HIV infection (76% max protection), notwithstanding all the three new aptamers proved to be capable of forming stable higher order dimeric G4s when annealed in K+-containing buffer, thus suggesting that the recognition of a hydrophobic pocket on the target glycoprotein by the aptamers represents a main structural feature for triggering their anti-HIV activity.
Related Literature
Neon-matrix spectroscopic and theoretical studies of the reactivity of titanium dimer with diatomic ligands: comparison of reactions with nitrogen and carbon monoxide
S. M. Souvi, N. Berkaïne, M. E. Alikhani, L. Manceron
DOI: 10.1039/B910056C
Quantitative analysis of 2H NMRT1Q, T1Z and T2 relaxation times in the SmA phase of a liquid crystal dendrimer
Valentina Domenici
DOI: 10.1039/B902168J
A matrix isolation and computational study of the [C, N, F, S] isomers
Tibor Pasinszki, Gábor Bazsó, Melinda Krebsz, György Tarczay
DOI: 10.1039/B913204J
Calculation of the surface tension of cyclic and aromatic hydrocarbons from Monte Carlo simulations using an anisotropic united atom model (AUA)
A. Ghoufi, V. Lachet
DOI: 10.1039/B823295D
Chiral recognition of 2-(3-benzoylphenyl)propionic acid (ketoprofen) by serum albumin: an investigation with microcalorimetry, circular dichroism and molecular modelling
Sandra Monti, Stefano Ottani, Francesco Manoli, Ilse Manet, Francesco Scagnolari, Barbara Zambelli, Giancarlo Marconi
DOI: 10.1039/B906021A
The origin of the large bending enhancement of the reaction of C2H2+ with methane: the effects of bending momentum, ruling out the precursor mechanism, and steps toward “Polanyi rules” for polyatomic reactions
Jianbo Liu, Scott L. Anderson
DOI: 10.1039/B908328F
Zeolitic polyoxometalates metal organic frameworks (Z-POMOF) with imidazole ligands and ε-Keggin ions as building blocks; computational evaluation of hypothetical polymorphs and a synthesis approach
L. Marleny Rodriguez Albelo, A. Rabdel Ruiz-Salvador, Dewi W. Lewis, Ariel Gómez, Pierre Mialane, Jérome Marrot, Anne Dolbecq, Alvaro Sampieri, Caroline Mellot-Draznieks
DOI: 10.1039/C004234J
A new ZnO nanotetrapods/SnO2nanoparticles composite photoanode for high efficiency flexible dye-sensitized solar cells
Wei Chen, Yongcai Qiu, Shihe Yang
DOI: 10.1039/C000584C
Tuning the surface potential of gold substrates arbitrarily with self-assembled monolayers with mixed functional groups
Wei-Chun Lin, Szu-Hsian Lee, Ying-Yu Chen, Yu-Chin Lin, Che-Hung Kuo
DOI: 10.1039/B902044F
You might also like
How should waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3) be handled?
Waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3...
How should N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine (CAS: 1318338-47-4) be stored?
N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine should be stored in a tightly sealed c...
What is the market or research trend for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1)?
The market for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1) is...
How should Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) be stored?
Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) ...
What regulatory guidelines apply to 2-Ethylpiperazine dihydrochloride (CAS: 438050-52-3)?
2-Ethylpiperazine dihydrochloride (CAS: 438050-52-3) is regulated under the Glob...
What regulatory guidelines apply to 1,1'-[1,3-Phenylenebis(methylene)]bis(3-methyl-1H-pyrrole-2,5-dione) (CAS: 119462-56-5)?
1,1'-[1,3-Phenylenebis(methylene)]bis(3-methyl-1H-pyrrole-2,5-dione) (CAS: 11946...
Are there alternatives to 5-Fluoro-2-(1-pyrrolidinyl)pyridine (CAS: 1287217-79-1) in synthesis?
Several alternatives can be used in the synthesis of 5-Fluoro-2-(1-pyrrolidinyl)...
What precautions should be taken when handling 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione (CAS: 153631-19-7)?
Proper personal protective equipment (PPE) must be worn when handling this compo...
What precautions should be taken when handling 6-Bromoimidazo[1,2-a]pyridin-8-amine (CAS: 676371-00-9)?
When handling 6-Bromoimidazo[1,2-a]pyridin-8-amine, it is important to wear appr...
Are there alternatives to (2S,4R)-4-(4-Nitrobenzyl)pyrrolidine-2-carboxylic acid hydrochloride (CAS: 1049740-22-8) in synthesis?
Alternatives to (2S,4R)-4-(4-Nitrobenzyl)pyrrolidine-2-carboxylic acid hydrochlo...
Source Journal
Organic & Biomolecular Chemistry

Organic & Biomolecular Chemistry (OBC) publishes original and high impact research and reviews in organic chemistry. We welcome research that shows new or significantly improved protocols or methodologies in total synthesis, synthetic methodology or physical and theoretical organic chemistry as well as research that shows a significant advance in the organic chemistry or molecular design aspects of chemical biology, catalysis, supramolecular and macromolecular chemistry, theoretical chemistry, mechanism-oriented physical organic chemistry, medicinal chemistry or natural products. Articles published in the journal should report new work which makes a highly-significant impact in the field. Routine and incremental work is generally not suitable for publication in the journal. More details about key areas of our scope are below. In all cases authors should include in their article clear rationale for why their research has been carried out.














![4-{2-[4-(2-Methyl-2-propanyl)phenyl]ethoxy}quinazoline structure 4-{2-[4-(2-Methyl-2-propanyl)phenyl]ethoxy}quinazoline structure](https://static.chemtradehub.com/structs/120/120928-09-8-d3db.webp)